期刊文献+

子宫外盆腔浆液性癌的起源

The Origin of Non-uterine Pelvic Serous Carcinomas
下载PDF
导出
摘要 子宫外盆腔浆液性癌包括卵巢浆液性癌、输卵管浆液性癌、腹膜浆液性癌。根据细胞分化程度可将卵巢浆液性癌分为低级别和高级别浆液性癌,两者临床特征、预后及分子特征完全不同,是两种不同的疾病。大量证据表明前者由卵巢的良性囊肿如浆液性囊腺瘤、内膜样囊肿等经交界性肿瘤逐步发展而来,而后者起源不明确。传统观点认为高级别浆液性癌起源于卵巢上皮,但对因携带遗传性乳腺癌-卵巢癌综合征易感基因(BRCA)突变行预防性输卵管卵巢切除术的患者手术标本行病理检查,可发现其输卵管伞端存在上皮内癌灶,可能为卵巢高级别浆液性癌的前驱病灶。输卵管浆液性癌及腹膜浆液性癌患者的临床及分子特征与卵巢高级别浆液性癌相似,且输卵管伞端也可见上皮内癌灶,故卵巢高级别浆液性癌、输卵管浆液性癌、腹膜浆液性癌可能均起源于输卵管伞端的上皮内癌灶。 Serous ovarian carcinoma, serous tubal carcinoma and serous peritoneal carcinoma comprise non-uterine pelvic serous carcinoma. Serous ovarian carcinoma can be divided into low-grade and high-grade subtypes according to cell differentiation. These two subtypes are distinct disease for the extreme variation in clinical manifestation, prognosis and endometrial cysts molecular feature. It was considered that low-grade subtype arises from benign cysts of ovarian like the serous cystadenomas and endometrial cysts by borderline tumors. The origin of high-grade subtype is unclear and believed to arise from ovarian surface epithelium traditionally. Pathological examination of the fallopian tube after risk-reducing salpingo-oophorectomy of BRCA mutation carriers found that serous tubal intraepithelial carcinoma (STIC) was usually present,which may be the precursor lesion for high-grade serous ovarian carcinoma. The same lesion was found at the fimbriae of patients diagnosed of serous tubal or peritoneal carcinoma which sharing the similar clinical and molecular characters to high-grade serous ovarian carcinoma. It was suggested that the above three types of non-uterine serous carcinoma may all arise from the STIC lesion located in fimbriae of uterine tube.
作者 赵婷 刘惜时
出处 《国际妇产科学杂志》 CAS 2015年第6期616-620,共5页 Journal of International Obstetrics and Gynecology
关键词 肿瘤 囊性 黏液性和浆液性 卵巢肿瘤 输卵管肿瘤 腹膜肿瘤 Neoplasms cystic mucinous and serous Ovarian neoplasms Fallopian tube neoplasms Peritoneal neoplasms
  • 相关文献

参考文献26

  • 1Goodman MT,Shvetsov YB. Incidence of ovarian,peritoneal,and fallopian tube carcinomas in the United States,1995-2004 [J]. Cancer Epidemiol Biomarkers Prev, 2009,18( 1 ): 132-139.
  • 2Siegel RL, Miller KD ,Jemal A. Cancer statistics, 2015[J]. CA Cancer J Clin, 2015,65( 1 ) : 5-29.
  • 3Chene G, Dauplat J, Radosevic-Robin N,et al. Tu-be or not tu-be: that is the question.., about serous ovarian carcinogenesis[J]. Crit Rev Oncol Hematol,2013,88( 1 ) : 134-143.
  • 4Delair D,Soslow RA. Key features of cxtrauterine pelvic serous tumours (fallopian tube, ovary, and peritoneum) [J]. Histopathology, 2012,61(3) : 329-339.
  • 5Usach I, Blansit K, Chen LM, et al. Survival differences in women with serous tubal, ovarian, peritoneal, and uterine carcinomas [J]. Am J Obstet Gynecol,2015,212(2) : 188. e1-6.
  • 6Koshiyama M,Matsumura N,Konishi I. Recent concepts of ovarian carcinogenesis : type I and type 11 [J]. Biomed Res Int, 2014,2014 : 934261.
  • 7Mandai M,Yamaguchi K,Matsumura N,et al. Ovarian cancer in endometriosis : molecular biology, pathology, and clinical management [J]. Int J Clin Oncol,2009,14(5) :383-391.
  • 8Zafrakas M,Grimbizis G,Timologou A,et al. Endometriosis and ovarian cancer risk:a systematic review of epidemiological studies [J]. Front Surg,2014,1 : 14.
  • 9Pearee CL,Templeman C,Rossing MA,et al. Association between endometriosis and risk of histological subtypes of ovarian cancer:a pooled analysis of case-control studies [J]. Lancet Oncol, 2012,13 (4) : 385-394.
  • 10Dinulescu DM,Ince TA,Quade BJ,et al. Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer [J]. Nat Med, 2005,11 ( 1 ) : 63-70.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部